Back to search

Acquired Aplastic Anemia

Data up to Jan 2025

Published2002
Citations370
References59

Total Citations Per Year

Abstract

References (59)

Solid Cancers after Bone Marrow Transplantation

1997 • 950 citations

Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program

1993 • 873 citations

The Pathophysiology of Acquired Aplastic Anemia

1997 • 522 citations

Malignant Tumors Occurring after Treatment of Aplastic Anemia

1993 • 461 citations

Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic Anemia

1989 • 425 citations

Acute Non-A–E Hepatitis in the United States and the Role of Hepatitis G Virus Infection

1997 • 422 citations

Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia

2003 • 385 citations

Transfusion-Associated Graft-versus-Host Disease

1990 • 347 citations

Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia

1995 • 329 citations

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

2003 • 321 citations

Hepatitis-Associated Aplastic Anemia

1997 • 303 citations

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia

1994 • 296 citations

Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes

1999 • 286 citations

Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experience

2000 • 273 citations

Progressive Telomere Shortening in Aplastic Anemia

1998 • 271 citations

Selection of patients for bone marrow transplantation in severe aplastic anemia

1975 • 267 citations

Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients

2000 • 267 citations

Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party

1995 • 218 citations

Induction of Fas (Apo-1, CD95)-Mediated Apoptosis of Activated Lymphocytes by Polyclonal Antithymocyte Globulins

1998 • 212 citations

The Drug Etiology of Agranulocytosis and Aplastic Anemia

1992 • 205 citations

Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?

2000 • 202 citations

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

2000 • 198 citations

Long-Term Outcome After Marrow Transplantation for Severe Aplastic Anemia

1998 • 196 citations

The treatment of severe acquired aplastic anemia

1995 • 190 citations

Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation

1996 • 183 citations

Guidelines for the diagnosis and management of acquired aplastic anaemia

2003 • 181 citations

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program

2002 • 176 citations

Late clonal diseases of treated aplastic anemia

2000 • 170 citations

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

2001 • 160 citations

Rabbit antithymocyte globulin (r‐ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy

1999 • 159 citations

Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia [see comments]

1991 • 155 citations

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial

2000 • 147 citations

Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia

2000 • 143 citations

Aplastic Anemia Complicating Orthotopic Liver Transplantation for Non-A, Non-B Hepatitis

1988 • 134 citations

Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children

1998 • 124 citations

PARVOVIRUS B19 IN HUMAN DISEASE

1997 • 120 citations

Current status of allogeneic bone marrow transplantation in acquired aplastic anemia

2000 • 115 citations

Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine

2000 • 108 citations

Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic Anemia

2001 • 104 citations

Limited heterogeneity of T cell receptor BV usage in aplastic anemia

2001 • 98 citations

Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults

1996 • 89 citations

PARTIAL T-CELL ACTIVATION AND ANERGY INDUCTION BY POLYCLONAL ANTITHYMOCYTE GLOBULIN1,2

1998 • 88 citations

Current Results of Bone Marrow Transplantation in Patients with Acquired Severe Aplastic Anemia

2000 • 86 citations

Long-term (5 to 20 years) Evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias

1990 • 82 citations

Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation

2001 • 81 citations

Haemopoietic growth factors in aplastic anaemia: a cautionary note

1994 • 66 citations

Impaired growth and elevated Fas receptor expression in PIGA+ stem cells in primary paroxysmal nocturnal hemoglobinuria

2000 • 61 citations

Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia

2000 • 50 citations

Incidence survey of aplastic anemia in China.

1991 • 49 citations

Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo

2002 • 47 citations

Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high‐dose methylprednisolone

1993 • 47 citations

Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony ‐ stimulating factor: a multicenter randomized controlled study

1997 • 43 citations

Regional patterns in the incidence of aplastic anemia in Thailand

1999 • 39 citations

Congenital bone marrow failure syndromes

2000 • 38 citations

Stimulation of granulopoiesis by high-dose recombinant human granulocyte colony-stimulating factor in children with aplastic anemia and very severe neutropenia

1994 • 38 citations

Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis

1997 • 35 citations

Drugs and chemicals.

1998 • 28 citations

Acute viral hepatitis in Hanoi, Viet Nam

1996 • 19 citations

Allogenic bone marrow transplantation for leukemias and aplastic anemia.

1997 • 9 citations

Cited By (0)

No citing papers found in database

Acquired Aplastic Anemia (2002) – Annals of Internal Medicine | Metascience Observatory Explorer